Steven Cohen's position in Crinetics Pharmaceuticals is currently worth $68.4M. That's 0.16% of their equity portfolio (169th largest holding). The investor owns 2.34% of the outstanding Crinetics Pharmaceuticals stock. The first Crinetics Pharmaceuticals trade was made in Q3 2019. Since then Steven Cohen bought shares twelve more times and sold shares on eleven occasions. The stake costed the investor $56.7M, netting the investor a gain of 21% so far.